Burning Rock Biotech (BNR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Burning Rock Biotech Limited, a precision oncology company, is set to unveil its unaudited financial results for Q1 2024 on May 29, 2024, before the U.S. market opens. Post-release, management will conduct a conference call to discuss the results, with live and archived webcasts available for shareholders and interested parties. The company is known for its NGS-based cancer testing and early detection solutions.
For further insights into BNR stock, check out TipRanks’ Stock Analysis page.
